Explore Business Standard
Fair trade regulator CCI on Tuesday approved US-based global investment firm Carlyle's proposal to acquire a 68.9 per cent stake in Roop Automotives Ltd. "The proposed combination involves certain inter-connected steps resulting in inter alia securities swap between HIL Shareholder and RAL, and the acquisition of up to 68.9 per cent shareholding in RAL by Investor," the regulator said in a release. CA Carob Investments (investor) is a Mauritius-based special-purpose vehicle owned and controlled by affiliates of the Carlyle Group Inc (Carlyle). As of September 30, 2024, Carlyle has USD 447 billion of assets under management. Roop Automotives Ltd (RAL) and Highway Industries Ltd (HIL) are engaged in the manufacturing and selling of auto components. "Commission approves the proposed combination involving inter-connected steps resulting in inter alia the acquisition of up to 68.9 per cent shareholding in Roop Automotives Ltd by CA Carob Investments (Investor)," CCI said. In another ..
Global private equity major Carlyle on Tuesday said it has set up a generic pharmaceutical platform in the country by partnering with Viyash Life Sciences. CA Hull Investments, an affiliated entity of CAP V Mauritius and Carlyle, and Viyash, have set up the platform, an official statement said, without giving any details of any investments. Viyash was set up by Hari Babu in partnership with Srihari Raju Kalidindi, and is a manufacturer of API (active pharmaceutical ingredients) intermediates, it said. Carlyle had first partnered with Viyash in June this year, during the latter's acquisition of majority stake in Symed Labs, a leading manufacturer of niche APIs to enable backward integration. Viyash has also acquired a controlling stake in Appco Pharma LLC, a formulations player focused on the US market which will help expand access to US generics market and formulation capabilities, the statement said. The company now has ten manufacturing facilities in India with a combined capaci